Tomorrows Breakthroughs Start with World-Class Researchers

We are a biotechnology and drug development company seeking novel, proprietary or biosimilar drugs that cover key therapeutic areas including metabolic, chemotherapeutic and monoclonal antibody (ADC) drugs with a goal of providing cost effective alternatives to drugs currently in the marketplace. Targeting high volume and costly branded pharmaceuticals, biopharmaceutical and drug delivery devices with the objective of penetrating their vast markets is a primary focus.  The objective is rapidly bring the drugs to market, expand market share and maximize revenues. 

 

We are using our research, development and manufacturing experience to a pipeline of drugs for the treatment of both chronic and acute medical conditions. Our company can provide the rapid progress of projects from concept to marketplace by minimizing costs and enhancing profitability.  Our overarching objective is avoid high cost and leveraging our networks of services in various disciplines.

​

We have partnered with Revisioning Bio to advance novel CAR-T technology.

​

​Our staff has enjoyed substantial research success and has experience in development management, GMP manufacturing.